東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Current trends in computational mode...

Kar, Supratik.

FindBook

Google Book

Amazon

博客來

Current trends in computational modeling for drug discovery

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Current trends in computational modeling for drug discovery/ edited by Supratik Kar, Jerzy Leszczynski.
其他作者:	Kar, Supratik.
出版者:	Cham :Springer International Publishing : : 2023.,
面頁冊數:	xv, 301 p. :ill. (some col.), digital ;24 cm.
內容註:	SBDD and its challenges -- In silico discovery of class IIb HDAC inhibitors: The state of art -- Role of computational modelling in drug discovery for Alzheimer's disease -- Computational Modeling in the Development of Antiviral Agents -- Targeted computational approaches to identify potential inhibitors for Nipah virus -- Role of Computational Modelling in Drug Discovery for HIV -- Recent insight of the emerging severe fever with thrombocytopenia syndrome virus: drug discovery, therapeutic options, and limitations -- Computational toxicological aspects in drug design and discovery, screening adverse effects -- Read-Across and RASAR tools from the DTC Laboratory -- Databases for Drug Discovery and Development.
Contained By:	Springer Nature eBook
標題:	Drug development - Data processing. -
電子資源:	https://doi.org/10.1007/978-3-031-33871-7
ISBN:	9783031338717

Current trends in computational modeling for drug discovery
Current trends in computational modeling for drug discovery[electronic resource] /edited by Supratik Kar, Jerzy Leszczynski. - Cham :Springer International Publishing :2023. - xv, 301 p. :ill. (some col.), digital ;24 cm. - Challenges and advances in computational chemistry and physics,v. 352542-4483 ;. - Challenges and advances in computational chemistry and physics ;v. 35..

SBDD and its challenges -- In silico discovery of class IIb HDAC inhibitors: The state of art -- Role of computational modelling in drug discovery for Alzheimer's disease -- Computational Modeling in the Development of Antiviral Agents -- Targeted computational approaches to identify potential inhibitors for Nipah virus -- Role of Computational Modelling in Drug Discovery for HIV -- Recent insight of the emerging severe fever with thrombocytopenia syndrome virus: drug discovery, therapeutic options, and limitations -- Computational toxicological aspects in drug design and discovery, screening adverse effects -- Read-Across and RASAR tools from the DTC Laboratory -- Databases for Drug Discovery and Development.

This contributed volume offers a comprehensive discussion on how to design and discover pharmaceuticals using computational modeling techniques. The different chapters deal with the classical and most advanced techniques, theories, protocols, databases, and tools employed in computer-aided drug design (CADD) covering diverse therapeutic classes. Multiple components of Structure-Based Drug Discovery (SBDD) along with its workflow and associated challenges are presented while potential leads for Alzheimer's disease (AD), antiviral agents, anti-human immunodeficiency virus (HIV) drugs, and leads for Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) disease are discussed in detail. Computational toxicological aspects in drug design and discovery, screening adverse effects, and existing or future in silico tools are highlighted, while a novel in silico tool, RASAR, which can be a major technique for small to big datasets when not much experimental data are present, is presented. The book also introduces the reader to the major drug databases covering drug molecules, chemicals, therapeutic targets, metabolomics, and peptides, which are great resources for drug discovery employing drug repurposing, high throughput, and virtual screening. This volume is a great tool for graduates, researchers, academics, and industrial scientists working in the fields of cheminformatics, bioinformatics, computational biology, and chemistry.

ISBN: 9783031338717

Standard No.: 10.1007/978-3-031-33871-7doiSubjects--Topical Terms:

1965635
Drug development
--Data processing.

LC Class. No.: RM301.25

Dewey Class. No.: 615.190113

Current trends in computational modeling for drug discovery
LDR:03291nmm a2200337 a 4500 001 2331999
003 DE-He213
005 20230630144358.0
006 m d
007 cr nn 008maaau
008 240402s2023 sz s 0 eng d
020 $a 9783031338717 $q (electronic bk.)
020 $a 9783031338700 $q (paper)
024 7 $a 10.1007/978-3-031-33871-7 $2 doi
035 $a 978-3-031-33871-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.25
072 7 $a PNRP $2 bicssc
072 7 $a SCI013050 $2 bisacsh
072 7 $a PNRP $2 thema
082 0 4 $a 615.190113 $2 23
090 $a RM301.25 $b .C976 2023
245 0 0 $a Current trends in computational modeling for drug discovery $h [electronic resource] / $c edited by Supratik Kar, Jerzy Leszczynski.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a xv, 301 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Challenges and advances in computational chemistry and physics, $x 2542-4483 ; $v v. 35
505 0 $a SBDD and its challenges -- In silico discovery of class IIb HDAC inhibitors: The state of art -- Role of computational modelling in drug discovery for Alzheimer's disease -- Computational Modeling in the Development of Antiviral Agents -- Targeted computational approaches to identify potential inhibitors for Nipah virus -- Role of Computational Modelling in Drug Discovery for HIV -- Recent insight of the emerging severe fever with thrombocytopenia syndrome virus: drug discovery, therapeutic options, and limitations -- Computational toxicological aspects in drug design and discovery, screening adverse effects -- Read-Across and RASAR tools from the DTC Laboratory -- Databases for Drug Discovery and Development.
520 $a This contributed volume offers a comprehensive discussion on how to design and discover pharmaceuticals using computational modeling techniques. The different chapters deal with the classical and most advanced techniques, theories, protocols, databases, and tools employed in computer-aided drug design (CADD) covering diverse therapeutic classes. Multiple components of Structure-Based Drug Discovery (SBDD) along with its workflow and associated challenges are presented while potential leads for Alzheimer's disease (AD), antiviral agents, anti-human immunodeficiency virus (HIV) drugs, and leads for Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) disease are discussed in detail. Computational toxicological aspects in drug design and discovery, screening adverse effects, and existing or future in silico tools are highlighted, while a novel in silico tool, RASAR, which can be a major technique for small to big datasets when not much experimental data are present, is presented. The book also introduces the reader to the major drug databases covering drug molecules, chemicals, therapeutic targets, metabolomics, and peptides, which are great resources for drug discovery employing drug repurposing, high throughput, and virtual screening. This volume is a great tool for graduates, researchers, academics, and industrial scientists working in the fields of cheminformatics, bioinformatics, computational biology, and chemistry.
650 0 $a Drug development $x Data processing. $3 1965635
650 0 $a Drug development $x Computer simulation. $3 768310
650 1 4 $a Structure-Based Drug Design. $3 3538435
650 2 4 $a Molecular Modelling. $3 3661500
650 2 4 $a Computational Chemistry. $3 3595554
650 2 4 $a Medicinal Chemistry. $3 892420
650 2 4 $a Pharmacology. $3 634543
700 1 $a Kar, Supratik. $3 2145303
700 1 $a Leszczynski, Jerzy. $3 1067151
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Challenges and advances in computational chemistry and physics ; $v v. 35. $3 3661499
856 4 0 $u https://doi.org/10.1007/978-3-031-33871-7
950 $a Chemistry and Materials Science (SpringerNature-11644)